Cogent Biosciences Inc.
COGT | NASDAQ
$32.70
+$0.70 (+2.19%)
Sep 22, 2026, 2:25 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 312K | 840K |
Cost of Revenue | 2.33M | 3.49M | 2.33M | 1.16M | 1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 10.13M |
Gross Profit | -2.33M | -3.49M | -2.33M | -1.16M | -1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.69M | -9.29M |
Operating Income | -389.09M | -362.04M | -333.36M | -307.6M | -299.66M | -288.47M | -275.94M | -260.43M | -244.6M | -227.3M | -208.13M | -193.65M | -170.89M | -159.66M | -147.84M | -129.73M | -112.73M | -94.17M | -75.55M | -61.37M | -98.75M | -88.86M |
Interest Income | 24.43M | 19.35M | 14.69M | 13.07M | 13.96M | 16.98M | 18.09M | 18.1M | 17.52M | 14.87M | 13.08M | 11.32M | 8.62M | 6.15M | 3.99M | 1.99M | 601K | 449K | 467K | 431K | 339K | 222K |
Pretax Income | -377.18M | -354.3M | -328.94M | -294.37M | -284.08M | -269.5M | -255.86M | -242.3M | -227.05M | -212.17M | -192.41M | -177.66M | -157.34M | -148.19M | -140.24M | -125.54M | -109.56M | -91.18M | -72.27M | -58.7M | -89.6M | -80.44M |
Net Income | -377.18M | -354.3M | -328.94M | -294.37M | -284.08M | -269.5M | -255.86M | -242.3M | -227.05M | -212.17M | -192.41M | -177.66M | -157.34M | -148.19M | -140.24M | -125.54M | -109.56M | -91.18M | -72.27M | -58.7M | -89.6M | -80.44M |
Selling & General & Admin | 98.37M | 79.92M | 63.58M | 51.34M | 48.77M | 45.49M | 43.28M | 41.1M | 38.75M | 36.88M | 34.38M | 31.87M | 29.3M | 27.46M | 26.21M | 24.34M | 22.47M | 21M | 19.64M | 19.86M | 20.44M | 18.34M |
Research & Development | 289.55M | 279.78M | 267.45M | 255.11M | 249.73M | 242.98M | 232.66M | 219.33M | 205.85M | 190.42M | 173.76M | 161.78M | 141.59M | 132.2M | 121.63M | 105.4M | 90.26M | 73.17M | 55.91M | 41.51M | 78.62M | 71.36M |
Other Expenses | -1.16M | -1.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5M | -10.13M |
Operating Expenses | 386.76M | 358.55M | 331.03M | 306.45M | 298.51M | 288.47M | 275.94M | 260.43M | 244.6M | 227.3M | 208.13M | 193.65M | 170.89M | 159.66M | 147.84M | 129.73M | 112.73M | 94.17M | 75.55M | 61.37M | 94.06M | 79.57M |
Interest Expense | 5.18M | 4.28M | 3.06M | 1.77M | 314K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 389.09M | 362.04M | 333.36M | 307.6M | 299.66M | 288.47M | 275.94M | 260.43M | 244.6M | 227.3M | 208.13M | 193.65M | 170.89M | 159.66M | 147.84M | 129.73M | 112.73M | 94.17M | 75.55M | 61.37M | 99.06M | 89.7M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 171.01M | 170.77M | 160.98M | 139.83M | 113.93M | 113.86M | 110.46M | 110.17M | 99.24M | 94.8M | 86.73M | 86.17M | 74.75M | 70.73M | 70.49M | 69.58M | 49.39M | 45.11M | 43.81M | 39.85M | 38.44M | 34.88M |
Shares Outstanding (Diluted) | 171.01M | 170.77M | 160.98M | 139.83M | 113.93M | 113.86M | 110.46M | 110.17M | 99.24M | 94.8M | 86.73M | 86.17M | 74.75M | 70.73M | 70.49M | 69.58M | 49.39M | 45.11M | 43.81M | 39.85M | 38.44M | 34.88M |
EPS (Basic) | -2.31 | -2.44 | -2.50 | -2.47 | -2.53 | -2.47 | -2.46 | -2.48 | -2.48 | -2.48 | -2.34 | -2.21 | -2.05 | -2.17 | -2.35 | -2.42 | -2.42 | -2.14 | -1.82 | -2.33 | -6.92 | -7.44 |
EPS (Diluted) | -2.31 | -2.44 | -2.50 | -2.47 | -2.53 | -2.47 | -2.46 | -2.48 | -2.48 | -2.48 | -2.34 | -2.21 | -2.05 | -2.17 | -2.35 | -2.42 | -2.42 | -2.14 | -1.82 | -2.33 | -6.92 | -7.44 |
EBITDA | -372.86M | -350.48M | -326.34M | -288.56M | -279.26M | -265.07M | -251.51M | -238.26M | -223.25M | -208.24M | -188.82M | -173.93M | -150.76M | -142.15M | -134.36M | -120.53M | -107.75M | -89.12M | -71.83M | -58.43M | -50.02M | -41.51M |
EBIT | -376.54M | -354.57M | -330.42M | -292.6M | -283.76M | -269.5M | -255.86M | -242.3M | -227.05M | -212.17M | -192.41M | -177.66M | -157.34M | -148.19M | -140.24M | -125.54M | -109.56M | -91.18M | -73.35M | -59.89M | -51.09M | -41.95M |
Depreciation & Amortization | 3.68M | 4.09M | 4.08M | 4.04M | 4.5M | 4.42M | 4.35M | 4.04M | 3.8M | 3.93M | 3.59M | 3.73M | 6.59M | 6.04M | 5.88M | 5.01M | 1.81M | 2.06M | 1.51M | 1.46M | 1.07M | 442K |
Add to Watchlist
Select watchlists to add or remove COGT